Featured News

  • CDC, Private Sector Laboratory Partners Build on Cross-Sector Collaboration Related to Emergency Preparation & Response

    June 13, 2019
    ATLANTA, G.A. – The Centers for Disease Control and Prevention (CDC) led a tabletop exercise with multiple partners to strengthen diagnostic laboratory surge testing capacity during an emergency response. The purpose of the exercise was to assess the utility of a newly created CDC Emergency Operations Center (EOC) Laboratory Task Force Guide, and to review the processes for commercial clinical laboratories to provide diagnosticContinue Reading »...
  • During emergencies and in everyday life, labs support public health goals

    June 05, 2019
    Clinical laboratory diagnostics advance public health goals in communities across the country every single day. For patients facing diabetes, heart disease, liver disease, kidney disease, prostate and colon cancers, anemia, infections and countless other common health conditions, routine lab tests are often the starting point for monitoring, diagnosing and treating disease. But our role in public health doesn’t stop there. Commercial labs have aContinue Reading »...
  • More Than 80 Leading Health Organizations Call on Congress to Modernize Clinical Diagnostic Oversight 

    May 06, 2019
    Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers reiterated the urgent need for Congressional action on a modernized regulatory framework for clinical laboratory diagnostics. Patients have yet to benefit from groundbreaking clinical diagnostics that monitor and support treatment for complex and rareContinue Reading »...
  • New analysis challenges GAO Report’s assumptions on lab billing

    April 16, 2019
    A new analysis from Braid-Forbes Health Research exposes the Government Accountability Office’s (GAO) flawed assumptions about lab billing practices by presenting survey data on more than 20 million actual clinical laboratory claims. Braid-Forbes’ analysis of publicly available data demonstrates that the GAO’s claim – that labs are receiving “excess payments” by charging Medicare for individual component tests in greater numbers rather than charging reducedContinue Reading »...
  • ACLA Elects 2019-2020 Board of Directors

    March 28, 2019
    Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced the election of its new Board of Directors for 2019-2020. Douglas M. VanOort, Chairman and CEO of NeoGenomics Laboratories will take on a new leadership role as ACLA Board Chair, replacing Dr. Curtis Hanson of Mayo Clinic Laboratories. Jerry Hussong, CEO of Sonic Healthcare USA was elected Vice Chair and John Kolozsvary, CEOContinue Reading »...
  • ACLA Files Reply Brief Ahead of Oral Arguments in ACLA v. Azar Appeal

    March 18, 2019
    HHS’ data collection process under PAMA disregards Congressional intent, jeopardizing lab access for millions of seniors Washington, D.C. – The American Clinical Laboratory Association (ACLA) filed a reply brief today ahead of oral arguments in the ACLA v. Azar appeal which has been scheduled for April 23, 2019. The brief reinforces ACLA’s argument that the U.S. Department of Health and Human Services (HHS) failedContinue Reading »...
  • With all eyes on cancer moonshot, labs continue to prove value

    March 12, 2019
    In 2019, an estimated 1.7 million new cancer cases will be diagnosed in the U.S., according to the American Cancer Society. As patients and their families across the country grapple with how to manage and overcome this painful disease, clinical labs are busy developing and providing innovative methods to identify, diagnose and monitor cancer. From early detection and evaluating the best course of treatment,Continue Reading »...
  • GAO acknowledges recent report projected lab spending based on hypothetical framework

    February 28, 2019
    The U.S. Government Accountability Office (GAO), often referred to as the “congressional watchdog,” is supposed to examine how taxpayer dollars are spent, and then provide Congress and federal agencies with objective, reliable information to help save money and work efficiently. And yet, following growing pushback to a recent report on laboratory billing practices in the Medicare program, James Cosgrove, GAO health care director andContinue Reading »...
  • ACLA Statement on New Genetic Testing Guidelines for Hereditary Breast Cancer

    February 27, 2019
    New guidelines issued by the American Society of Breast Surgeons call for genetic testing to be available for all breast cancer patients Washington, D.C. – In response to the American Society of Breast Surgeons’ (ASBrS) recently released guidelines on genetic testing for hereditary breast cancer, ACLA President Julie Khani issued the following statement: “Our ability to pinpoint the start of breast cancer at itsContinue Reading »...
  • Clinical laboratory diagnostics play key role in understanding heart health

    February 22, 2019
    Through innovation and advances in science, the health system has made significant progress in identifying and treating cardiovascular disease – the most significant development being the reduction in heart attacks and strokes. In fact, from 1980 to 2014, the number of Americans dying from cardiovascular disease dropped in half. While we now know more than ever before about the risk factors associated with heartContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19